Table 4.
Reference | Year | N | SNB+ (%) | SNB+/FS+ | SNB+/FS− | FNR (%) |
---|---|---|---|---|---|---|
Wada [7] | 2004 | 569 | 159 (28%) | 133 (83.6%) | 26 | 16.3% |
Arora et al. [5] | 2008 | 327 | 108 (33%) | 78 (72.2%) | 30 | 27.8% |
McLaughlin et al. [8] | 2008 | 931 | 306 (32.8%) | 170 (55.6%) | 136 | 44.4% |
van de Vrande et al. [3] | 2009 | 615 | 176 (28.6%) | 126 (71.6%) | 50 | 28.4% |
Ali et al. [9] | 2008 | 94 | 30 (33.3%) | 23 (76.7%) | 7 | 23.3% |
Chan et al. [10] | 2008 | 5298 | 1845 (34.8%) | 1124 (60.9%) | 721 | 39.1% |
This study | — | 628 | 179 (28.5%) | 78 (43.6%) | 101 | 56.4% |
N: number of patients, SNB+: sentinel node biopsy with positive result, FS+: frozen section with positive result, FS−: frozen section with negative result, FNR: false negative rate.